IndiaCOVID-19Ministry of Health and Family WelfareHealth

India’s Cumulative COVID-19 Vaccination Coverage exceeds 179.53 Cr

More than 18.23 lakh Vaccine Doses administered in the last 24 hours

Recovery Rate currently stands at 98.70%

4,184 New Cases reported in the last 24 hours

India’s Active Caseload currently stands at 44,488

Weekly Positivity Rate is presently at 0.58%

With the administration of more than 18.23 lakh Doses (18,23,329) vaccine doses in the last 24 hours, India’s COVID-19 vaccination coverage has exceeded 179.53 Cr (1,79,53,95,649) as per provisional reports till 7 am today.

This has been achieved through 2,09,22,227 sessions. The break-up of the cumulative figure as per the provisional report till 7 am today include:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 1,04,02,375
2nd Dose 99,80,218
Precaution Dose 42,79,747
FLWs 1st Dose 1,84,11,037
2nd Dose 1,74,68,936
Precaution Dose 64,77,578
Age Group 15-18 years 1st Dose 5,56,54,876
2nd Dose 3,24,98,481
Age Group 18-44 years 1st Dose 55,29,72,639
2nd Dose 45,25,52,270
Age Group 45-59 years 1st Dose 20,24,67,568
2nd Dose 18,20,74,949
Over 60 years 1st Dose 12,65,52,468
2nd Dose 11,33,93,853
Precaution Dose 1,02,08,654
Precaution Dose 2,09,65,979
Total 1,79,53,95,649

 

6,554 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,24,20,120.

Consequently, India’s recovery rate stands at 98.70%.

4,184 new cases were reported in the last 24 hours.

India’s Active Caseload is presently at 44,488. Active cases constitute 0.10% of the country’s total Positive Cases.

The testing capacity across the country continues to be expanded. The last 24 hours saw a total of 8,73,974 tests being conducted. India has so far conducted over 77.60 Cr (77,60,82,445) cumulative tests.

While testing capacity has been enhanced across the country, Weekly Positivity Rate in the country currently stands at 0.58% and the Daily Positivity rate is reported to be 0.48%.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker